Efficacy and safety of imeglimin in combination with insulin in Japanese patients with type 2 diabetes: results of TIMES 3 trial

被引：0
|
作者：
Dubourg, J. [1 ]
Watada, H. [2 ]
Thang, C. [1 ]
Kaneko, T. [3 ]
Fouqueray, P. [1 ]
机构：
[1] Poxel SA, Lyon, France
[2] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan
[3] Poxel SA, Tokyo, Japan
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
637
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [21] Benefits and disadvantages of combination therapy with imeglimin and metformin in patients with type 2 diabetes
    Ito, Hiroyuki
    Tsugami, Emiko
    Chiaki, I.
    Miura, Shun
    Matsumoto, Suzuko
    Inoue, Hideyuki
    Antoku, Shinichi
    Yamasaki, Tomoko
    Mori, Toshiko
    Togane, Michiko
    EXPERT OPINION ON PHARMACOTHERAPY, 2025,
  • [22] Rosiglitazone: safety and efficacy in combination with insulin in poorly controlled type 2 diabetes mellitus patients treated with insulin alone
    Garg, Ranjna
    Gopal, Jayanthi
    Jones, Geraint Rhys
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (01) : 1 - 6
  • [23] The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Diamant, Michaela
    Schernthaner, Guntram
    Lebovitz, Harold E.
    Inzucchi, Silvio E.
    Bailey, Clifford J.
    DIABETES CARE, 2014, 37 (07) : 1924 - 1930
  • [24] The efficacy and safety of berberine in combination with cinnamon supplementation in patients with type 2 diabetes: a randomized clinical trial
    Mansour, Asieh
    Sajjadi-Jazi, Sayed Mahmoud
    Gerami, Hadis
    Khorasanian, Atie Sadat
    Moalemzadeh, Behnam
    Karimi, Sara
    Afrakoti, Nima Mohamadi
    Mofid, Vahid
    Mohajeri-Tehrani, Mohammad Reza
    Hekmatdoost, Azita
    EUROPEAN JOURNAL OF NUTRITION, 2025, 64 (02)
  • [25] The Efficacy and Safety of Imeglimin as Add-On Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Inzucchi, Silvio
    Bailey, Clifford J.
    Schernthaner, Guntram
    Diamant, Michaela
    Lebovitz, Harold E.
    DIABETES, 2012, 61 : A257 - A257
  • [26] Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial
    Tong Zhang
    Mingrun Lin
    Wangen Li
    Xiuyun Fan
    Tao Du
    Yunjuan Zhao
    Xiaodan Zhang
    Advances in Therapy, 2016, 33 : 178 - 185
  • [27] Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial
    Zhang, Tong
    Lin, Mingrun
    Li, Wangen
    Fan, Xiuyun
    Du, Tao
    Zhao, Yunjuan
    Zhang, Xiaodan
    ADVANCES IN THERAPY, 2016, 33 (02) : 178 - 185
  • [28] Efficacy and safety of a combination of miglitol, metformin and insulin aspart in the treatment of type 2 diabetes
    Ke, Tingyu
    Cheng, Guoliang
    Tan, Liping
    Zhou, Xiangming
    Miao, Yuanyuan
    Du, Shigang
    Wang, Jia
    Pan, Yi
    Bi, Jingjie
    Zhao, Lin
    Zhi, Yunxia
    Zhao, Ling
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (10) : 2171 - 2177
  • [29] Long-Term Efficacy and Safety of Ipragliflozin plus Insulin in Japanese Patients with Type 2 Diabetes (IOLITE)
    Ishihara, Hisamitsu
    Yamaguchi, Susumu
    Nakao, Ikko
    Okitsu, Akira
    Asahina, Seitaro
    DIABETES, 2017, 66 : A335 - A335
  • [30] Long-term treatment with imeglimin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes (Times 2)
    Kaku, K.
    Dubourg, J.
    Thang, C.
    Kaneko, T.
    Fouqueray, P.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S306 - S306
12345